2019 Chronic Lymphocytic Leukaemia (CLL) IGHV mutation status (pilot)

Scheme description
2019 CLL IGHV variant detection pilot - DNA and lyophilised cells are distributed for analysis. Analysis will include any technique for the detection of IGHV mutation status.
Disorders/Gene target(s)
IGHV mutation status
Clinical cases
Four
Testing/analysis
Any methodology
Sample type
DNA and lyophilised cells
Techniques
Any
Assessment
Technical, Genotyping and Interpetation
Eligibility
Any ERIC certified laboratory
Languages
English
ISO1743 Accredited EQA
No
EQA timeline
Sample dispatchAutum/Winter 2019
Testing periodFour weeks
Assessment resultsTBC
Final Summary reportTBC
Other information
Fee
£0.00
GenQA code
2019CLLIGHV
« Return to EQA scheme list
Go to top